In 2019, the FDA cleared an external trigeminal nerve stimulation (eTNS) device to treat ADHD symptoms in children ages 7-12 years. In contrast to earlier findings, a new trial in England suggested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback